Disease‐modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Ke Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Behavioral Health, Nemours Children's Health, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Shared decision‐making is one promising solution to addressing barriers in use of disease‐modifying therapies for adolescents and young adults (AYAs) with sickle cell disease (SCD). A thorough understanding of decisional needs can guide the development of decisional supports and promote shared decision‐making. Procedure Informed by the Ottawa Decision Support Framework (ODSF), we conducted a qualitative analysis to assess decisional needs and supports reported by AYAs with SCD, their caregivers, and healthcare providers. Semi‐structured qualitative interviews were conducted with AYAs and their caregivers, and online crowdsourcing was used with SCD providers. Thematic and descriptive content analyses were used to summarize perspectives on decisional needs and supports regarding disease‐modifying therapies.
Results
Fourteen AYAs ( M age = 21 years, 57% male, 93% non‐Hispanic Black, 79% HbSS), 11 caregivers (80% female, 100% non‐Hispanic Black), and 40 healthcare providers (65% female, 65% non‐Hispanic White, M years in practice = 14.8 years, 75% physicians) participated. Thematic analysis revealed needs related to: decisional conflict, inadequate knowledge, unclear expectations, and inadequate supports and resources. Six forms of support emerged as important for decision‐making: establishing an open and trusting patient/family–provider relationship, providing information, accepting ambivalence and unreadiness, supporting implementation of a decision, addressing inadequate health and social services, and promoting adequate social, emotional, and instrumental help.
Conclusions
This is the first study to assess decisional needs and supports for AYAs with SCD considering disease‐modifying therapies. Additional research is needed to examine which decision supports are the most impactful to promote effective shared decision‐making in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Behavioral Health, Nemours Children's Health, Philadelphia, Pennsylvania, USA.
- Center for Healthcare Delivery Science, Nemours Children's Health, Philadelphia, Pennsylvania, USA.
- Nemours Cardiac Center, Nemours Children's Health, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Ke Ding, Lori Crosby, Aimee K Hildenbrand
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ding, K., Bear, B., Sood, E., Alderfer, M., Crosby, L., & Hildenbrand, A. K. (2024). Disease‐modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30999
Vancouver
Ding K, Bear B, Sood E, Alderfer M, Crosby L, Hildenbrand AK. Disease‐modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30999
BibTeX
@article{Ding2024,
author = {Ding, Ke and Bear, Benjamin and Sood, Erica and Alderfer, Melissa and Crosby, Lori and Hildenbrand, Aimee K},
title = {Disease‐modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30999}
}
EUVIMED